VALIDATION OF AN INFLIXIMAB POPULATION PHARMACOKINETIC MODEL FOR MAINTENANCE DOSING IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Singer, Jason, Tong, Dominic, Cumming, Celine, Hughes, Jasmine, Holmes, Maya, Sferra, Thomas, Moses, Jonathan, Finkler, Michael
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2024)
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2024)
Get full text
Journal Article
INSURANCE DENIALS AND DELAYS IN CARE FOR PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Behbahani-Nejad, Pareenaz, Finkler, Michael, Momotaz, Hasina, Perry, Sharon, Young, Denise, Sferra, Thomas, Moses, Jonathan
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2024)
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2024)
Get full text
Journal Article
VALIDATION OF AN INFLIXIMAB POPULATION PHARMACOKINETIC MODEL FOR MAINTENANCE DOSING IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Singer, Jason, Tong, Dominic, Cumming, Celine, Hughes, Jasmine, Holmes, Maya, Sferra, Thomas, Moses, Jonathan, Finkler, Michael
Published in Inflammatory bowel diseases (25.01.2024)
Published in Inflammatory bowel diseases (25.01.2024)
Get full text
Journal Article
Sa558 OVERALL RATE AND PREDICTIVE FACTORS FOR DURABILITY OF INFLIXIMAB IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS AT 3 AND 5 YEARS: A SINGLE CENTER EXPERIENCE
Siegel, Jaclyn, Siegel, Brittany, Nasab, Arian, Minich, Nori, Finkler, Michael D., Moses, Jonathan
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Get full text
Journal Article
903-P: Switch from Insulin Glargine to Degludec in a Pediatric Population with T1D Leads to Decrease in DKA but No Change in Glycemic Control: A Retrospective Review
CHILUKOTI, PADMAJA, MALAY, SINDHOOSHA, FINKLER, MICHAEL, WOOD, JAMIE R., MACLEISH, SARAH A.
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
Mo1910 SAFETY AND EFFICACY OF SUPRATHERAPEUTIC SERUM INFLIXIMAB LEVELS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
Swamy, Supraja S., Nasab, Arian, Malay, Sindhoosha, Perry, Sharon, Splawski, Judy B., Finkler, Michael D., Moses, Jonathan
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2020)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2020)
Get full text
Journal Article
Retrospective Assessment of an Adalimumab Model–Informed Precision Dosing Support Tool for Use in Pediatric Inflammatory Bowel Disease
Avalos, Yesenia, Gothard, M. David, Moses, Jonathan, Finkler, Michael
Published in The journal of pediatric pharmacology and therapeutics (2023)
Published in The journal of pediatric pharmacology and therapeutics (2023)
Get full text
Journal Article
Natural History of Pediatric Patients With Crohn's Disease Treated With Mesalamine Therapy
Young, Denise D., Perry, Sharon, Malay, Sindhoosha, Sferra, Thomas J., Finkler, Michael, Moses, Jonathan
Published in JPGN reports (01.11.2023)
Published in JPGN reports (01.11.2023)
Get full text
Journal Article
Comparison of Short-Term Outcomes for Standard Versus Nonstandard Induction Dosing of Infliximab for Pediatric Inflammatory Bowel Disease
Nasab, Arian S., Finkler, Michael, DeLozier, Sarah, Sferra, Thomas J., Splawski, Judy, Moses, Jonathan
Published in The journal of pediatric pharmacology and therapeutics (01.01.2022)
Published in The journal of pediatric pharmacology and therapeutics (01.01.2022)
Get full text
Journal Article